Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 701 to 750 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
701\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HRD1 PROTEIN ISOFORM A; SYNOVIOLIN1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.191556\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.722002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265312284\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SYVN1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
702\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8-LIKE PROTEIN 1 ISOFORM C; EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8-RELATED PROTEIN 1; EPS8-RELATED PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0987306\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.372159\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265291448\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EPS8L1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
703\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY MEMBER 2 (WASP-FAMILY PROTEIN MEMBER 2) (VERPROLIN HOMOLOGY DOMAIN-CONTAINING PROTEIN 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.1433\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.540454\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26514745\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
704\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY MEMBER 3 (WASP-FAMILY PROTEIN MEMBER 3) (VERPROLIN HOMOLOGY DOMAIN-CONTAINING PROTEIN 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.178008\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.671355\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265147351\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
WASF3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
705\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WISKOTT-ALDRICH SYNDROME PROTEIN FAMILY MEMBER 1 (WASP-FAMILY PROTEIN MEMBER 1) (VERPROLIN HOMOLOGY DOMAIN-CONTAINING PROTEIN 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.145472\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.548646\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26514729\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
WASF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
706\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.220284\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.830799\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265147166\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AOF2\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
707\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0319701\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.120575\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265147004\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RCOR2\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
708\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0359748\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.135679\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265146412\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RCOR3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
709\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
REST COREPRESSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0422874\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.159487\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265146376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RCOR1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
710\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
F-ACTIN CAPPING PROTEIN BETA SUBUNIT (CAPZ BETA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.238765\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.900943\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265016766\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CAPZB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
711\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
F-ACTIN CAPPING PROTEIN ALPHA-3 SUBUNIT (CAPZ ALPHA-3) (GERM CELL- SPECIFIC PROTEIN 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0330141\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.124574\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.265015974\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CAPZA3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
712\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HISTONE DEACETYLASE 2 (HD2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.52666\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.98825\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264886206\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DJ153G14.2 (POSSIBLE CA BINDING PROTEIN SIMILAR TO NEFA) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0697761\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.263425\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264880326\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
714\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MULTIPLE COAGULATION FACTOR DEFICIENCY 2; NEURAL STEM CELL DERIVED NEURONAL SURVIVAL PROTEIN; MULTIPLE COAGULATION FACTOR DEFICIENCY PROTEIN 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0858635\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.32416\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264879998\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MCFD2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
715\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HISTONE DEACETYLASE 1 (HD1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.582904\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.20068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264874493\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HDAC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
716\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
P28 ING5. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.105213\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.397328\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264801373\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ING5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
717\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARP2/3 COMPLEX 16 KDA SUBUNIT (P16-ARC) (ACTIN-RELATED PROTEIN 2/3 COMPLEX SUBUNIT 5). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.402903\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.52156\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264795999\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARPC5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
718\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INTERFERON-RELATED DEVELOPMENTAL REGULATOR 2 (SKMC15 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0750554\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.28346\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264783038\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HYAL3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.424703\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.60405\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264769178\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARPC5L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
720\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN 258. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0317441\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.119935\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264677534\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZMYM6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DJ470L14.3 (NOVEL PROTEIN SIMILAR TO THE ARP2/3 PROTEIN COMPLEX SUBUNIT P21-ARC (ARC21)). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.381101\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.43987\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264677367\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
722\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIMILAR TO ACTIN-RELATED PROTEIN 3-BETA. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.322726\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.21932\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.264677033\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACTR3B\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
723\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTIN-LIKE PROTEIN 3 (ACTIN-RELATED PROTEIN 3) (ACTIN-2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.528875\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.99819\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
ACTR3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
724\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTIN-RELATED PROTEIN 2/3 COMPLEX SUBUNIT 1A (SOP2-LIKE PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.355858\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.3445\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264676832\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARPC1A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
725\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARP2/3 COMPLEX 21 KDA SUBUNIT (P21-ARC) (ACTIN-RELATED PROTEIN 2/3 COMPLEX SUBUNIT 3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.392968\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.48471\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264676604\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARPC3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
726\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NARDILYSIN PRECURSOR (EC 3.4.24.61) (N-ARGININE DIBASIC CONVERTASE) (NRD CONVERTASE) (NRD-C). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0787172\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.297409\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26467659\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NRD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
727\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN 262; CELL DEATH INHIBITING RNA. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0398851\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.150694\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.264676099\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZMYM4\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
728\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CONSERVED OLIGOMERIC GOLGI COMPLEX COMPONENT 3 (VESICLE DOCKING PROTEIN SEC34 HOMOLOG) (P94). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
COG3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
729\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACTIN-LIKE PROTEIN 2 (ACTIN-RELATED PROTEIN 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.390781\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.47645\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264676081\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACTR2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
730\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN 261 (DXS6673E PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.030934\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.116875\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264675936\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZMYM3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
731\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN 198 (FUSED IN MYELOPROLIFERATIVE DISORDERS PROTEIN) (REARRANGED IN ATYPICAL MYELOPROLIFERATIVE DISORDER PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0311669\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.117755\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26467581\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZMYM2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
732\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARP2/3 COMPLEX 41 KDA SUBUNIT (P41-ARC) (ACTIN-RELATED PROTEIN 2/3 COMPLEX SUBUNIT 1B). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.317947\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.20127\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264675718\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARPC1B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C-TERMINAL BINDING PROTEIN 1 (CTBP1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.349374\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.32007\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264663238\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CTBP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
B-CELL LYMPHOMA 6 PROTEIN (BCL-6) (ZINC FINGER PROTEIN 51) (LAZ-3 PROTEIN) (BCL-5). \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0869475\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.328537\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.264650557\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
BCL6\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZINC FINGER PROTEIN SLUG (NEURAL CREST TRANSCRIPTION FACTOR SLUG) (SNAIL HOMOLOG 2). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
SNAI2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PAS DOMAIN CONTAINING SERINE/THREONINE KINASE; PAS-SERINE/THREONINE KINASE. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
PASK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"B-CELL CLL/LYMPHOMA 6, MEMBER B (ZINC FINGER PROTEIN); ZINC FINGER PROTEIN 62. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0692921\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.261825\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264650434\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BCL6B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C-TERMINAL BINDING PROTEIN 2 (CTBP2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.398698\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.50657\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264639545\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CTBP2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEROXISOMAL CARNITINE OCTANOYLTRANSFERASE (EC 2.3.1.-) (COT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.117061\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.442554\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264512353\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CROT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN C20ORF45 (CGI-107). \vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0385694\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.145821\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.264498255\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLMO2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
ZCCHC8\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BARDET-BIEDL SYNDROME 7 PROTEIN ISOFORM A; BBS2-LIKE 1. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
BBS7\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
743\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
HSDL2\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
744\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.10892\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.411799\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264497971\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
INTS10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
745\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BA508N22.1 (HSPC025) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0296502\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.1121\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.26449777\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 11 (EIF-3 P25) (EIF3K) (MUSCLE SPECIFIC GENE M9 PROTEIN) (PTD001) (HSPC029) (ARG134). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.216085\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.816964\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264497579\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF3K\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.192847\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.729107\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264497529\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CLUAP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
748\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE RNA-BINDING PROTEIN 7 (RNA BINDING MOTIF PROTEIN 7). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0771388\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.291643\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264497348\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RBM7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
749\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ERYTHROID DIFFERENTIATION AND DENUCLEATION FACTOR 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0317812\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.120157\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264497283\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLMO1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
750\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 6 INTERACTING PROTEIN (HSPC021/HSPC025). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.115708\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.437464\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.264497193\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF3EIP\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/